Experimental cell therapy targets tough lung cancers
NCT ID NCT05676749
First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 24 times
Summary
This early-phase study tested a personalized cell therapy (C-TIL051) for people with advanced non-small cell lung cancer that no longer responded to standard anti-PD1 drugs. Participants provided a tumor sample to grow immune cells, then received chemotherapy followed by an infusion of those cells plus additional immune-boosting drugs. The goal was to check safety and see if the cancer would shrink. Only one person enrolled before the study was stopped.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC NON SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Allegheny Health Network-West Penn Hospital
Pittsburgh, Pennsylvania, 15224, United States
-
Duke Center for Cancer Immunotherapy
Raleigh, North Carolina, 27710, United States
-
Ochsner MD Anderson Cancer Center
New Orleans, Louisiana, 70121, United States
Conditions
Explore the condition pages connected to this study.